Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 7(12): e52861, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23285206

RESUMO

The objective of the present study is to evaluate bone loss at implant abutments coated with a soda-lime glass containing silver nanoparticles subjected to experimental peri-implantitis. Five beagle dogs were used in the experiments, 3 implants were installed in each quadrant of the mandibles. Glass/n-Ag coted abutments were connected to implant platform. Cotton floss ligatures were placed in a submarginal position around the abutment necks and the animals were subject to a diet which allowed plaque accumulation, and after 15 weeks the dogs were sacrificed. Radiographs of all implant sites were obtained at the beginning and at the end of the experimentally induced peri-implantitis. The radiographic examination indicated that significant amounts of additional bone loss occurred in implants without biocide coating, considering both absolute and relative values of bone loss. Percentages of additional bone loss observed in implants dressed with a biocide coated abutment were about 3 times lower (p<0.006 distal aspect; and p<0.031 at mesial aspect) than the control ones. Within the limits of the present study it seems promising the use of soda-lime glass/nAg coatings on abutments to prevent peri-implant diseases.


Assuntos
Perda do Osso Alveolar/diagnóstico por imagem , Dente Suporte , Implantes Dentários/efeitos adversos , Desinfetantes/administração & dosagem , Doenças Maxilares/diagnóstico por imagem , Peri-Implantite/diagnóstico por imagem , Titânio , Algoritmos , Perda do Osso Alveolar/etiologia , Animais , Materiais Revestidos Biocompatíveis/efeitos adversos , Materiais Revestidos Biocompatíveis/farmacologia , Dente Suporte/efeitos adversos , Implantação Dentária Endóssea/efeitos adversos , Implantação Dentária Endóssea/métodos , Implantação Dentária Endóssea/microbiologia , Planejamento de Prótese Dentária , Cães , Doenças Maxilares/etiologia , Peri-Implantite/complicações , Peri-Implantite/prevenção & controle , Radiografia , Propriedades de Superfície , Titânio/efeitos adversos
2.
Microb Pathog ; 43(2-3): 114-9, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17583465

RESUMO

The adherence of 11 pneumococcal strains to polystyrene was studied and expressed as the number of colony-forming units (CFU) recovered per 10(6)CFU of initial inoculum. Three strains were considered as strong adherent (>100CFU/10(6)), three as medium adherent (10-100CFU/10(6)), and five as low adherent (<10CFU/10(6)). All serotype 3 strains were low adherent whilst serotypes 23F and 19F behaved as strong or medium adherent. The impact of gerbil sera on adherence of six selected pneumococcal strains (one strong adherent, one medium adherent, and four low adherents) to abiotic material was also studied under two experimental conditions. In the presence of sera, the adherence ability of the strong, medium, and one low adherent strains decreased significantly. On the other hand, the adherence significantly increased in all strains when sera were removed following preincubation of bacteria exposed to sera, although such increase was statistically significant for five of them. Finally, the ability of two (one strong adherent and one low adherent) strains to induce otitis media in gerbils was also evaluated; the strong adherent strain behaved significantly more virulent than the less adherent in terms of ear damage and animal weight loss.


Assuntos
Aderência Bacteriana/imunologia , Aderência Bacteriana/fisiologia , Otite Média/imunologia , Otite Média/microbiologia , Soro/imunologia , Streptococcus pneumoniae/fisiologia , Streptococcus pneumoniae/patogenicidade , Animais , Peso Corporal , Contagem de Colônia Microbiana , Modelos Animais de Doenças , Orelha Média/microbiologia , Orelha Média/patologia , Gerbillinae , Humanos , Poliestirenos , Virulência
3.
Spine (Phila Pa 1976) ; 31(10): 1113-8, 2006 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-16648745

RESUMO

STUDY DESIGN: Prospective, double-cohort study. OBJECTIVE: To evaluate conservative and percutaneous vertebroplasty (PV) management of osteoporotic vertebral fractures. SUMMARY OF BACKGROUND DATA: PV is an elective alternative to conservative management for the treatment of a painful osteoporotic vertebral fracture. METHODS: We performed a prospective study consisting of 101 consecutive patients who underwent PV and 27 patients who refused PV treatment and were managed conservatively. We used a data evaluation and outcomes system that was developed to evaluate the outcomes of surgical intervention. RESULTS: Patients that elected for PV as a treatment of their fractures had significantly more pain and functional impairment before the procedure than the patients of the conservative group (P < 0.001). The pain, functional, and general health scores of the PV group were improved from the preoperative mean values (P < 0.001) in all postoperative periods. Compared with the conservative treatment group, there was a significant difference at month 3. However, no statistical differences on function were observed between these groups at 6 months and 1 year posttreatment. CONCLUSIONS: PV demonstrated a rapid and significant relief of pain and improved the quality of life. PV election for treatment of painful osteoporotic vertebral fracture after 6 weeks of conservative treatment was based on pain and functional impairment.


Assuntos
Fraturas por Compressão/cirurgia , Procedimentos Cirúrgicos Minimamente Invasivos , Osteoporose Pós-Menopausa/cirurgia , Fraturas da Coluna Vertebral/cirurgia , Fusão Vertebral/métodos , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Feminino , Fraturas por Compressão/etiologia , Fraturas por Compressão/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Osteoporose Pós-Menopausa/complicações , Osteoporose Pós-Menopausa/fisiopatologia , Dor/etiologia , Dor/fisiopatologia , Dor/cirurgia , Estudos Prospectivos , Qualidade de Vida , Recuperação de Função Fisiológica , Fraturas da Coluna Vertebral/etiologia , Fraturas da Coluna Vertebral/fisiopatologia , Resultado do Tratamento
4.
J Antimicrob Chemother ; 56(4): 783-6, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16144869

RESUMO

OBJECTIVE: To evaluate the effect of delayed administration of erythromycin in the course of acute otitis media caused by an erythromycin-susceptible Streptococcus pneumoniae strain in the gerbil model. METHODS: The bacterium was inoculated by transbullar challenge in the middle ear (ME) and antibiotic treatment at different doses was administered at various times thereafter. RESULTS: When 2.5 mg/kg of erythromycin was administered as a single dose 2, 5, 18 or 21 h post-inoculation (pi) the bacterial eradication rate was 55, 40, 0 and 0%, respectively. A higher dose (5 mg/kg) administered also as a single dose 2, 5, 18 and 21 h pi achieved bacterial eradication rates of 62.5, 43.8, 0 and 0%, respectively. Using a very high dose (50 mg/kg) repeated three times at 3 h intervals (total dose 150 mg/kg) and starting the treatment 21 h pi only achieved bacterial eradication in 25% of cases. The concentration of erythromycin achieved in the ME 90 min after administration of 5 mg/kg 5 or 21 h pi was very similar (0.74 and 0.79 mg/L) but the ME half-life was longer (98.2 min) with the early administration as compared with the delayed form (47.5 min), which could partially explain the different results. Further experiments showed that the failures observed with the delayed administration were not related to the time elapsed from antibiotic administration to ME sampling or selection of antibiotic-resistant mutants. CONCLUSION: Bacteriological and clinical efficacies were significantly diminished if antibiotic administration was delayed.


Assuntos
Antibacterianos/administração & dosagem , Antibacterianos/uso terapêutico , Eritromicina/administração & dosagem , Eritromicina/uso terapêutico , Otite Média/tratamento farmacológico , Infecções Pneumocócicas/tratamento farmacológico , Animais , Antibacterianos/sangue , Antibacterianos/farmacocinética , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Eritromicina/sangue , Eritromicina/farmacocinética , Gerbillinae , Testes de Sensibilidade Microbiana , Fatores de Tempo , Resultado do Tratamento
5.
Clin Biochem ; 38(10): 920-4, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16081057

RESUMO

OBJECTIVE: The effects of insulin or insulin resistance on the lipid profile seem to change with age. The aim of this study was to analyze insulin levels and an insulin resistance index and to investigate the relationship between these and the lipid profile in a population-based sample of Spanish prepubertal children. METHODS: 1048 (524 boys and 524 girls) randomly selected prepubertal children were studied. Children were 6 to 8 years old with a mean age of 6.7. Plasma lipid, FFA and insulin levels were measured. The homeostatic model assessment (HOMA) was calculated as an indicator of insulin resistance. RESULTS: When analyzing percentile values of insulin, HOMA and FFA by sex, we observed that girls had significantly higher insulin concentrations than boys (except at the 10th percentile) and significantly higher FFA (except at the 90th percentile) with no significant differences between sexes for HOMA. Multivariate regression analyses showed that insulin was positively associated with glucose, triglycerides and apoB in boys but not in girls, and negatively associated with FFA in both genders. CONCLUSIONS: We report here data about the distribution of insulin in the Spanish prepubertal population. The higher levels of insulin in prepubertal girls could indicate that girls start to be more insulin resistant than boys at this age, although other manifestations of insulin resistance are not yet detectable.


Assuntos
Homeostase/fisiologia , Insulina/sangue , Lipídeos/sangue , Puberdade/sangue , Índice de Massa Corporal , Criança , Feminino , Humanos , Resistência à Insulina , Masculino , Fatores Sexuais , Espanha
6.
Spine (Phila Pa 1976) ; 30(1): 87-92, 2005 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-15626987

RESUMO

STUDY DESIGN: Retrospective review of all percutaneous vertebroplasties performed in the authors' institution from November 1994 to June 2002. OBJECTIVE.: To determine the factors affecting the outcome of percutaneous vertebroplasty for the treatment of persistent painful osteoporotic fractures. SUMMARY OF BACKGROUND DATA: Percutaneous vertebroplasty is an efficient procedure to treat pain due to osteoporotic vertebral fracture. However, the patient population that is most likely to benefit from this procedure is uncertain, and the inclusion and exclusion criteria for an ideal candidate have varied widely in the literature. METHODS: A retrospective review of 278 percutaneous vertebroplasty procedures for osteoporotic fractures at 423 levels was performed. Sociodemographic, clinical, radiologic, and procedural data were analyzed as parameters for prognosis significance by univariate and multivariate analysis with logistic regression to estimate the strength of influence of each variable. RESULTS: The presence of two or less symptomatic vertebrae (P < 0.03), the American Society of Anesthesiologists status I (P < 0.001), the presence of signal changes on magnetic resonance imaging (P < 0001), and the collapse of the vertebral body less than 70% (P < 0.001) were assessed as parameters for prognostic significance. Multivariate analysis also showed a significant correlation between the American Society of Anesthesiologists score and height loss of the vertebral body and the final outcome. The presence of signal changes on magnetic resonance imaging showed the highest odds ratio adjusted. CONCLUSIONS: Appropriate patient selection is essential for achieving clinical success. Better results can be expected in patients with an American Society of Anesthesiologists score of I and when the level managed is confirmed by magnetic resonance imaging and the vertebral body height loss is less than 70%.


Assuntos
Vértebras Lombares/lesões , Osteoporose/complicações , Fraturas da Coluna Vertebral/diagnóstico , Fraturas da Coluna Vertebral/cirurgia , Vértebras Torácicas/lesões , Adulto , Idoso , Idoso de 80 Anos ou mais , Dor nas Costas/cirurgia , Estatura , Cimentos Ósseos/uso terapêutico , Feminino , Fraturas Espontâneas/diagnóstico , Fraturas Espontâneas/etiologia , Fraturas Espontâneas/cirurgia , Humanos , Modelos Logísticos , Vértebras Lombares/cirurgia , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Satisfação do Paciente , Valor Preditivo dos Testes , Estudos Retrospectivos , Fraturas da Coluna Vertebral/etiologia , Vértebras Torácicas/cirurgia , Resultado do Tratamento
7.
Clin Infect Dis ; 39(7): 1024-9, 2004 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-15472856

RESUMO

BACKGROUND: Simplified highly active antiretroviral therapy (HAART) regimens are becoming widely used, particularly as a result of the side effects of and difficult compliance with protease inhibitor (PI) therapy. However, the long-term efficacy of HAART has not been properly assessed. METHODS: We performed a prospective study of 110 patients infected with human immunodeficiency virus type 1 (HIV-1) with undetectable virus load who discontinued PI therapy and initiated therapy with nevirapine without changing nucleoside analogues. Reasons for switching were treatment simplification (45%), lipodystrophy (24%), renal problems (23%), and dyslipidemia (8%). HIV-1 load, CD4 cell count, and fasting biochemistry profiles were performed at the time of switching (baseline) and every 3-4 months thereafter. The aim of the study was to evaluate the long-term efficacy and safety of this combination. RESULTS: Sixty-eight patients (61.8%) had a duration of follow-up of 3 years. The mean increase in the CD4 cell count after 3 years was 90 cells/microL (13.8% from baseline). Virus loads remained undetectable in all patients but 9 (8.2%). Triglyceride levels dramatically improved at 12 months (a 75% decrease; P<.02) and remained statistically significant over time (P<.04). The same occurred with serum cholesterol levels: there was an initial reduction of 25% (P<.02) and at the end of the follow-up period (P<.015). However, at the long-term evaluation, complete normalization of mean serum cholesterol and triglyceride levels could not be achieved. Sixteen patients (14.5%) had to stop therapy as a result of nevirapine-associated side effects. CONCLUSIONS: The switching of a PI to nevirapine is a safe and well-tolerated option for maintaining long-term virological suppression and immunological control. Three years after starting nevirapine therapy, rates of hypercholesterolemia and hypertriglyceridemia improved, although normal cholesterol and triglyceride values were not achieved.


Assuntos
Fármacos Anti-HIV/efeitos adversos , Fármacos Anti-HIV/uso terapêutico , Infecções por HIV/tratamento farmacológico , Nevirapina/efeitos adversos , Nevirapina/uso terapêutico , Adulto , Idoso , Terapia Antirretroviral de Alta Atividade , Contagem de Linfócito CD4 , Feminino , Humanos , Hipercolesterolemia/induzido quimicamente , Hipertrigliceridemia/induzido quimicamente , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Carga Viral
8.
J Am Coll Cardiol ; 44(8): 1578-83, 2004 Oct 19.
Artigo em Inglês | MEDLINE | ID: mdl-15489088

RESUMO

OBJECTIVES: The aim of this study was to analyze modifications in the plasma protein map during an acute coronary syndrome (ACS) using proteomics. BACKGROUND: Proteomics is a new technology that allows the detection and identification of several proteins at a given time in a sample. METHODS: Plasma from 19 patients, 11 with acute myocardial infarction (AMI) and 8 with unstable angina (UA), was investigated. The control group included nine age-matched volunteers. RESULTS: In two-dimensional electrophoresis using a pH range of 4 to 7, constant differences were found in at least four different areas within the plasma protein map. In area 1, we identified the presence of seven alpha(1)-antitrypsin (AAT) isoforms in plasma from control subjects. alpha(1)-antitrypsin isoform 1 was undetectable in plasma from UA and AMI patients. The AAT isoforms 5, 6, and 7 were reduced in plasma from AMI patients when compared with UA patients. Three fibrinogen gamma chain isoforms were identified in area 2. Fibrinogen gamma chain isoforms 1 and 2 were increased in AMI patients with respect to UA patients. Five apolipoprotein A-I isoforms were identified in area 3. All of them were reduced in plasma from AMI patients with respect to UA patients. In area 4, the gamma-immunoglobulin heavy chains were detected and were found increased in plasma from ACS patients. CONCLUSIONS: Plasma proteomic analysis makes it possible to develop a map of the protein isoforms that are expressed in plasma during an ACS.


Assuntos
Angina Instável/sangue , Proteínas Sanguíneas/análise , Infarto do Miocárdio/sangue , Proteômica , Doença Aguda , Idoso , Apolipoproteína A-I/sangue , Feminino , Fibrinogênio/análise , Humanos , Masculino , Pessoa de Meia-Idade , Isoformas de Proteínas/sangue , Valores de Referência , Fatores de Risco , Síndrome , alfa 1-Antitripsina/análise
10.
Mov Disord ; 17(5): 934-41, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12360542

RESUMO

Rapid eye movement (REM) sleep behavior disorder (RBD) is frequently associated with Parkinson's disease (PD) and may anticipate its diagnosis by several years. We assessed the presence of motor dyscontrol during REM sleep in treatment-naïve PD patients and investigated the putative effect of levodopa (L-dopa) treatment on motor activity. Overnight sleep studies were performed on 15 previously untreated PD patients and 14 controls at baseline, again after a 3- to 9-month treatment period with a low dose of L-dopa, and 2 to 5 days after treatment discontinuation (in 8 patients). No differences in sleep parameters were observed across groups or treatment conditions. None of the patients met criteria for RBD at baseline, whereas 5 patients were symptomatic at the time of the second sleep study. A quantitative analysis of electromyographic (EMG) activity during REM sleep showed a lower phasic twitching activity in untreated PD than in controls. However, an increase in both phasic twitching and tonic activity was found after treatment with L-dopa. Discontinuation of treatment resulted in a return to pretreatment values of phasic but not of tonic EMG activity. Thus, the increase in phasic activity seems to depend on the effects of L-dopa, whereas the increase in tonic EMG activity during REM sleep might be caused by other factors such as the progression of disease. Potential implications for the understanding of the relationship between RBD and PD are discussed.


Assuntos
Agonistas de Dopamina/farmacologia , Agonistas de Dopamina/uso terapêutico , Levodopa/farmacologia , Levodopa/uso terapêutico , Doença de Parkinson/tratamento farmacológico , Sono REM/efeitos dos fármacos , Idoso , Eletromiografia/efeitos dos fármacos , Feminino , Humanos , Masculino , Transtornos dos Movimentos/diagnóstico , Tono Muscular/efeitos dos fármacos , Índice de Gravidade de Doença
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...